PUNEET AGGARWAL: Open Payments
NPI 1649560798 · TAYLOR, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,227 in 67 payments from 21 companies in 2025. Trend: 2023 $1,053 · 2024 $1,091 · 2025 $1,227
Food & beverage: $1,227
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 21 | $305 |
| Vanda Pharmaceuticals Inc. | 6 | $186 |
| AstraZeneca Pharmaceuticals LP | 9 | $160 |
| GlaxoSmithKline, LLC. | 4 | $66 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $51 |
| Abbott Laboratories | 3 | $47 |
| Lundbeck LLC | 2 | $47 |
| ABBVIE INC. | 2 | $41 |
| Sumitomo Pharma America, Inc. | 2 | $39 |
| Viatris Specialty LLC | 2 | $39 |
Products named: FANAPT, Wegovy, Rybelsus, REXULTI, Ozempic, BREZTRI, CAPLYTA, AIRSUPRA.
Industry payments across MI — which companies pay providers there.
